Neuilly sur Seine, France

Beatrice Guardiola-Lemaitre


Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Neuilly sur Seine, FR (1994 - 1995)
  • Saind Cloud, FR (1997)
  • Saint-Cloud, FR (1995 - 1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Beatrice Guardiola-Lemaitre: An Innovator in Melatoninergic Treatments

Introduction

Beatrice Guardiola-Lemaitre is a prominent inventor based in Neuilly sur Seine, France. With an impressive portfolio of 14 patents, she has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating melatoninergic disorders.

Latest Patents

Among her most recent inventions are innovative alkylated (hetero) cyclic compounds. These compounds, represented by a specific chemical formula, have important applications in creating medicinal products aimed at treating disorders related to the melatoninergic system. Her patents detail methods of manufacturing these compounds and their effectiveness in remedying such health issues, underscoring her role as a leader in this specialized area of research.

Career Highlights

Beatrice works with Adir et Compagnie, a company focused on advancing chemical and pharmaceutical innovations. Her work at the company has positioned her prominently in the field, showcasing her commitment to developing effective treatments for melatoninergic disorders.

Collaborations

Throughout her career, Beatrice has collaborated with esteemed colleagues, including Pierre Renard and Gerard Adam. These collaborative efforts have enhanced her research and contributed to her innovative approaches in medicinal chemistry.

Conclusion

Beatrice Guardiola-Lemaitre is a remarkable force in the realm of medicinal innovation. Her dedication to advancing treatments through her patents not only reflects her expertise but also her passion for improving patient health outcomes. As she continues to innovate, her contributions will undoubtedly leave a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…